Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA1 | P15085 | 2/20 | 0.55 |
| ▸ | CPB1 | P15086 | 1/20 | 0.55 |
| ▸ | CPA3 | P15088 | 1/20 | 0.55 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.55 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.54 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.49 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | LAP3 | P28838 | 5/20 | 0.47 |
| ▸ | ANPEP | P15144 | 3/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21689939 | 1.00 | CPA1 (0.55) | CPA1CPB1CPA3CPB2SLC15A1 | |
| SCHEMBL3495957 | 1.00 | CPA1 (0.55) | CPA1CPB1CPA3CPB2SLC15A1 | |
| SCHEMBL10657726 | 0.85 | CPA1 (0.58) | CPA1CPB1CPA3CPB2SLC15A1 | |
| SCHEMBL7276908 | 0.85 | CPA1 (0.58) | CPA1CPB1CPA3CPB2SLC15A1 | |
| SCHEMBL7322202 | 0.85 | CPA1 (0.58) | CPA1CPB1CPA3CPB2SLC15A1 | |
| SCHEMBL197907 | 0.82 | EPHX1 (0.64) | CPA1CPB1CPA3CPB2SLC15A1 | |
| SCHEMBL287736 | 0.82 | EPHX1 (0.64) | CPA1CPB1CPA3CPB2SLC15A1 | |
| SCHEMBL123055 | 0.82 | EPHX1 (0.64) | CPA1CPB1CPA3CPB2SLC15A1 | |
| SCHEMBL10433814 | 0.82 | CSNK1E (0.58) | CPA3SLC15A1ALPIPKMPTGS1 | |
| SCHEMBL6425554 | 0.82 | EPHX1 (0.62) | SLC15A1ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2423 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140057850-A1 | PEPTIDE FOR USE IN THE TREATMENT OF SKIN CONDITIONS | ORGANOBALANCE GMBH (DE) | 2014-02-27 | — | — | US | claimed |
| EP-0211744-B1 | PEPTIDIC AMINO-ALCOHOL DERIVATIVES CONTAINING A TETRA-SUBSTITUTED CARBON ATOM, INHIBITORS OF RENIN AND OF ACID PROTEASES, PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS | SANOFI (FR) | 1991-12-04 | — | — | EP | claimed |
| WO-2026085582-A1 | PROTEIN CAGES | THE UNIVERSITY OF SYDNEY (AU) | 2026-04-30 | — | — | WO | disclosed |
| EP-4731641-A1 | BIO-ENGINEERED FLAGELLIN-DERIVED SCAFFOLD BACKBONE AND USES THEREOF | EpitogenX Limited (GB) | 2026-04-29 | — | — | EP | disclosed |
| US-20260085104-A1 | METHODS OF DETECTING IMMUNE CELLS | BIOSCEPTRE AUST PTY LTD (AU) | 2026-03-26 | — | — | US | disclosed |
| EP-4710935-A2 | NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USES THEREOF | Aravax Pty Ltd (AU) | 2026-03-18 | — | — | EP | disclosed |
| EP-4705440-A1 | NAMPT FUSION PROTEINS | Monash University (AU) | 2026-03-11 | — | — | EP | disclosed |
| US-20260055150-A1 | GRAIL-1 PEPTIDE PRODUCTS AND METHODS | UNIV MICHIGAN (US) | 2026-02-26 | — | — | US | disclosed |
| US-20260049121-A1 | SUPRAMOLECULAR HIGH AFFINITY PROTEIN-BINDING SYSTEM FOR PURIFICATION OF BIOMACROMOLECULES | UNIV JOHNS HOPKINS (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260022147-A1 | PLACENTA EXPRESSED PROTEINS FOR USE IN THE TREATMENT OF TENDON INJURY | UNIV COLLEGE CORK NATIONAL UNIV OF IRELAND CORK (IE) | 2026-01-22 | — | — | US | disclosed |
| EP-4680108-A1 | PEPTIDE MULTIMER PRODUCTS AND METHODS | The Regents of The University of Michigan (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-0292800-A2 | Amino acid derivatives | MERCK PATENT GmbH (DE) | 1988-11-30 | — | — | EP | disclosed |
| EP-0286813-A2 | Renin-inhibiting amino acid derivatives | MERCK PATENT GmbH (DE) | 1988-10-19 | — | — | EP | disclosed |
| EP-0272444-A2 | Renin-inhibiting peptides | MERCK PATENT GmbH (DE) | 1988-06-29 | — | — | EP | disclosed |
| US-4746648-A | HYPOTENSIVE, ANTIULCER | Sanofi, Institut National de la Recherche Medicale (FR) | 1988-05-24 | — | — | US | disclosed |
| EP-0262318-A2 | Renin-inhibiting amino acid derivatives | MERCK PATENT GmbH (DE) | 1988-04-06 | — | — | EP | disclosed |
| US-4725580-A | ARTERIAL TENSION | SANOFI (FR) | 1988-02-16 | — | — | US | disclosed |
| US-4721776-A | Amino acid derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-01-26 | — | — | US | disclosed |
| EP-0249096-A2 | Renin-inhibiting amino acid derivatives | MERCK PATENT GmbH (DE) | 1987-12-16 | — | — | EP | disclosed |
| EP-0222283-A2 | Amino-acid derivatives | MERCK PATENT GmbH (DE) | 1987-05-20 | — | — | EP | disclosed |